{"title":"Feasibility of Coplanar VMAT for Brain Metastases Using Halcyon With Knowledge-based Planning from Non-coplanar Plan.","authors":"Yusuke Sakai, Kazuki Kubo, Kenji Matsumoto, Makoto Hosono, Hajime Monzen","doi":"10.21873/invivo.13893","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aim: </strong>This study aimed to clarify the feasibility of creating coplanar single-isocenter volumetric modulated arc therapy (SI-VMAT) with a Halcyon using a knowledge-based planning system based on non-coplanar plans for treating multiple brain metastases.</p><p><strong>Patients and methods: </strong>A knowledge-based RapidPlan (RP) planning model was built using 32 TrueBeam SI-VMAT plans including one full arc and three non-coplanar partial arcs. To confirm its applicability across different beam geometries using the Halcyon system, the model was validated on the basis of the root-mean-square error (RSME), deviation rate, and absolute differences between estimated and actual dose-volume histograms (DVHs). Dosimetric performance of TrueBeam and Halcyon plans was then compared for 10 patients.</p><p><strong>Results: </strong>The average RSME values for the Halcyon and TrueBeam plans were 0.75±0.40 Gy and 0.46±0.28 Gy, respectively (<i>p</i><0.05). Using the model for Halcyon plan creation, deviations from the estimated DVH boundaries were mainly observed in the low-dose region (<9 Gy), while the actual DVH closely aligned with the estimated DVH in the intermediate- and higher-dose regions. For comparison of dosimetric performance, statistically significant differences were found in the gradient index, conformity index, and normal brain volumes receiving ≥12 Gy, ≥18 Gy, and ≥27 Gy. However, these differences were deemed clinically negligible, with less than 1% disparity in the above doses to the normal brain.</p><p><strong>Conclusion: </strong>The RP model can effectively predict doses for Halcyon, regardless of different beam configurations. Coplanar SI-VMAT with Halcyon can feasibly be used in clinical applications, such as the treatment of multiple brain metastases.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"39 2","pages":"894-901"},"PeriodicalIF":1.8000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"In vivo","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21873/invivo.13893","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background/aim: This study aimed to clarify the feasibility of creating coplanar single-isocenter volumetric modulated arc therapy (SI-VMAT) with a Halcyon using a knowledge-based planning system based on non-coplanar plans for treating multiple brain metastases.
Patients and methods: A knowledge-based RapidPlan (RP) planning model was built using 32 TrueBeam SI-VMAT plans including one full arc and three non-coplanar partial arcs. To confirm its applicability across different beam geometries using the Halcyon system, the model was validated on the basis of the root-mean-square error (RSME), deviation rate, and absolute differences between estimated and actual dose-volume histograms (DVHs). Dosimetric performance of TrueBeam and Halcyon plans was then compared for 10 patients.
Results: The average RSME values for the Halcyon and TrueBeam plans were 0.75±0.40 Gy and 0.46±0.28 Gy, respectively (p<0.05). Using the model for Halcyon plan creation, deviations from the estimated DVH boundaries were mainly observed in the low-dose region (<9 Gy), while the actual DVH closely aligned with the estimated DVH in the intermediate- and higher-dose regions. For comparison of dosimetric performance, statistically significant differences were found in the gradient index, conformity index, and normal brain volumes receiving ≥12 Gy, ≥18 Gy, and ≥27 Gy. However, these differences were deemed clinically negligible, with less than 1% disparity in the above doses to the normal brain.
Conclusion: The RP model can effectively predict doses for Halcyon, regardless of different beam configurations. Coplanar SI-VMAT with Halcyon can feasibly be used in clinical applications, such as the treatment of multiple brain metastases.
期刊介绍:
IN VIVO is an international peer-reviewed journal designed to bring together original high quality works and reviews on experimental and clinical biomedical research within the frames of physiology, pathology and disease management.
The topics of IN VIVO include: 1. Experimental development and application of new diagnostic and therapeutic procedures; 2. Pharmacological and toxicological evaluation of new drugs, drug combinations and drug delivery systems; 3. Clinical trials; 4. Development and characterization of models of biomedical research; 5. Cancer diagnosis and treatment; 6. Immunotherapy and vaccines; 7. Radiotherapy, Imaging; 8. Tissue engineering, Regenerative medicine; 9. Carcinogenesis.